Page last updated: 2024-09-03

ulipristal acetate and Blood Loss, Surgical

ulipristal acetate has been researched along with Blood Loss, Surgical in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Bongers, MY; de Milliano, I; Hehenkamp, WJK; Huirne, JAF; Radder, C; Thurkow, AL; van de Lande, J; van de Ven, PM; van Vliet, H1
Alessandri, F; Ferrero, S; Leone Roberti Maggiore, U; Vellone, VG; Venturini, PL1

Trials

1 trial(s) available for ulipristal acetate and Blood Loss, Surgical

ArticleYear
Ulipristal acetate vs gonadotropin-releasing hormone agonists prior to laparoscopic myomectomy (MYOMEX trial): Short-term results of a double-blind randomized controlled trial.
    Acta obstetricia et gynecologica Scandinavica, 2020, Volume: 99, Issue:1

    Topics: Adult; Blood Loss, Surgical; Contraceptive Agents, Hormonal; Double-Blind Method; Female; Gonadotropin-Releasing Hormone; Humans; Laparoscopy; Leiomyoma; Netherlands; Norpregnadienes; Operative Time; Sutures; Uterine Myomectomy; Uterine Neoplasms

2020

Other Studies

1 other study(ies) available for ulipristal acetate and Blood Loss, Surgical

ArticleYear
Three-month treatment with ulipristal acetate prior to laparoscopic myomectomy of large uterine myomas: a retrospective study.
    European journal of obstetrics, gynecology, and reproductive biology, 2016, Volume: 205

    Topics: Adult; Blood Loss, Surgical; Databases, Factual; Female; Humans; Laparoscopy; Leiomyomatosis; Norpregnadienes; Operative Time; Retrospective Studies; Treatment Outcome; Uterine Myomectomy; Uterine Neoplasms

2016